A praeeclampsia a legveszélyesebb terhességi kórképek közé tartozik, egyike a vezető terhességi halálokoknak. A betegség kialakulása a placentához köthető. A patomechanizmusban kulcsszerepet tulajdonítanak az elégtelen NO-szintézisnek. A placentában az endothelialis izoforma (eNOS) a jellemző, ennek ismert zavarait foglaljuk össze. Csökkentheti a NO-szintézist szubsztrát- (arginin), kofaktor- (tetrahidrobiopterin, BH4) és kalciumhiány. Praeeclampsiában nőhet a nem észteresített szabad zsírsavak (FFA), a szolubilis VEGF-receptor (sVEGFR), az aszimmetrikus dimetil-arginin, a reaktív oxigéngyökök és a glükóz szérumszintje. Ezek különböző útvonalakon csökkentik a NO mennyiségét. Ismert a praeeclampticus placenták egy részében az enzim csökkent BH4 iránti affinitása, ami a NO-szintézis csökkenésén túl emelkedett szuperoxid-termelést is okozhat. A praeeclampsiához – nem kellően bizonyítottan – eNOS-polimorfizmusokat is társítottak (D298E, –786T→C). A dohányzásnak preventív hatása van praeeclampsia ellen. A hatásmechanizmus nem tisztázott, a NO-szintézisre fokuszálva is ellentmondásokkal teli. A dohányfüst az eNOS expresszióját csökkenti, az aktivitását emelő Ser1177 és az enzimaktivitást gátló Thr495-foszforilációt egyaránt fokozza. Az oxidatív stresszel a NO-szint közvetlenül csökken. A dohányzás csökkenti az FFA-szintet, ami az eNOS-aktivitás növekedését okozhatja. A dohányzás CO-ot termel, ami részben NO-mimikáló hatásával pótolhatja a NO-t. Orv. Hetil., 2010, 151, 2125–2135.
Stella, C. L., Sibai, B. M.: Preeclampsia: Diagnosis and management of the atypical presentation. J. Matern. Fetal. Neonatal. Med., 2006, 19, 381–386.
Sibai B. M. , 'Preeclampsia: Diagnosis and management of the atypical presentation ' (2006 ) 19 J. Matern. Fetal. Neonatal. Med. : 381 -386.
Roberts, J. M., Cooper D. W.: Pathogenesis and genetics of preeclampsia. Lancet, 2001, 357, 53–56.
Cooper D. W. , 'Pathogenesis and genetics of preeclampsia ' (2001 ) 357 Lancet : 53 -56.
Molnár, M., Sütö, T., Tóth, T. és mtsa: Prolonged blockade of nitric oxide synthesis in gravid rats produces sustained hypertension, proteinuria, thrombocytopenia, and intrauterine growth retardation. Am. J. Obstet. Gynecol., 1994, 170, 1458–1466.
Tóth T. , 'Prolonged blockade of nitric oxide synthesis in gravid rats produces sustained hypertension, proteinuria, thrombocytopenia, and intrauterine growth retardation ' (1994 ) 170 Am. J. Obstet. Gynecol. : 1458 -1466.
Kukor, Z., Tóth, M.: Ca(2+)-dependent and Ca(2+)-independent NO-synthesizing activities of human primordial placenta. Acta Physiol. Hung., 1994, 82, 313–319.
Tóth M. , 'Ca(2+)-dependent and Ca(2+)-independent NO-synthesizing activities of human primordial placenta ' (1994 ) 82 Acta Physiol. Hung. : 313 -319.
Kukor, Z., Mészáros, G., Hertelendy, F. és mtsa: Calcium-dependent nitric oxide synthesis is potently stimulated by tetrahydrobiopterin in human primordial placenta. Placenta, 1996, 17, 69–73.
Hertelendy F. , 'Calcium-dependent nitric oxide synthesis is potently stimulated by tetrahydrobiopterin in human primordial placenta ' (1996 ) 17 Placenta : 69 -73.
Yildirim, A., Altinkaynak, K., Aksoy, H. és mtsai: Plasma xanthine oxidase, superoxide dismutase and glutathione peroxidase activities and uric acid levels in severe and mild pre-eclampsia. Cell. Biochem. Funct., 2004, 22, 213–217.
Aksoy H. , 'Plasma xanthine oxidase, superoxide dismutase and glutathione peroxidase activities and uric acid levels in severe and mild pre-eclampsia ' (2004 ) 22 Cell. Biochem. Funct. : 213 -217.
López-Jaramillo, P., Arenas, W. D., García, R. G. és mtsai: The role of the L-arginine-nitric oxide pathway in preeclampsia. Ther. Adv. Cardiovasc. Dis., 2008, 2, 261–275.
García R. G. , 'The role of the L-arginine-nitric oxide pathway in preeclampsia ' (2008 ) 2 Ther. Adv. Cardiovasc. Dis. : 261 -275.
Venardos, K., Zhang, W. Z., Lang, C. és mtsa: Effect of peroxynitrite on endothelial L-arginine transport and metabolism. Int. J. Biochem. Cell. Biol., 2009, 41, 2522–2527.
Lang C. , 'Effect of peroxynitrite on endothelial L-arginine transport and metabolism ' (2009 ) 41 Int. J. Biochem. Cell. Biol. : 2522 -2527.
Noris, M., Todeschini, M., Cassis, P. és mtsai: L-arginine depletion in preeclampsia orients nitric oxide synthase toward oxidant species. Hypertension, 2004, 43, 614–622.
Cassis P. , 'L-arginine depletion in preeclampsia orients nitric oxide synthase toward oxidant species ' (2004 ) 43 Hypertension : 614 -622.
Sankaralingam, S., Xu, H., Davidge, S. T.: Arginase contributes to endothelial cell oxidative stress in response to plasma from women with preeclampsia. Cardiovasc. Res., 2010, 85, 194–203.
Davidge S. T. , 'Arginase contributes to endothelial cell oxidative stress in response to plasma from women with preeclampsia ' (2010 ) 85 Cardiovasc. Res. : 194 -203.
Savvidou, M. D., Hingorani, A. D., Tsikas, D. és mtsai: Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia. Lancet, 2003, 361, 1511–1517.
Tsikas D. , 'Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia ' (2003 ) 361 Lancet : 1511 -1517.
McBride, A. E., Silver, P. A.: State of the arg: protein methylation at arginine comes of age. Cell, 2001, 106, 5–8.
Silver P. A. , 'State of the arg: protein methylation at arginine comes of age ' (2001 ) 106 Cell : 5 -8.
Böger, R. H., Diemert, A., Schwedhelm, E. és mtsai: The role of nitric oxide synthase inhibition by asymmetric dimethylarginine in the pathophysiology of preeclampsia. Gynecol. Obstet. Invest., 2010, 69, 1–13.
Schwedhelm E. , 'The role of nitric oxide synthase inhibition by asymmetric dimethylarginine in the pathophysiology of preeclampsia ' (2010 ) 69 Gynecol. Obstet. Invest. : 1 -13.
Maas, R.: Pharmacotherapies and their influence on asymmetric dimethylargine (ADMA). Vasc. Med., 2005, 10, S49–S57.
Maas R. , 'Pharmacotherapies and their influence on asymmetric dimethylargine (ADMA) ' (2005 ) 10 Vasc. Med. : S49 -S57.
Kukor, Z., Valent, S., Tóth, M.: Regulation of nitric oxide synthase activity by tetrahydrobiopterin in human placentae from normal and pre-eclamptic pregnancies. Placenta, 2000, 21, 763–772.
Tóth M. , 'Regulation of nitric oxide synthase activity by tetrahydrobiopterin in human placentae from normal and pre-eclamptic pregnancies ' (2000 ) 21 Placenta : 763 -772.
Gao, Y. T., Roman, L. J., Martásek, P. és mtsai: Oxygen metabolism by endothelial nitric-oxide synthase. J. Biol. Chem., 2007, 282, 28557–28565.
Martásek P. , 'Oxygen metabolism by endothelial nitric-oxide synthase ' (2007 ) 282 J. Biol. Chem. : 28557 -28565.
Dhanjal, M. K., Owen, E. P., Anthony, J. A. és mtsai: Association of pre-eclampsia with the R563Q mutation of the beta-subunit of the epithelial sodium channel. BJOG, 2006, 113, 595–598.
Anthony J. A. , 'Association of pre-eclampsia with the R563Q mutation of the beta-subunit of the epithelial sodium channel ' (2006 ) 113 BJOG : 595 -598.
Camilleri, R. S., Peebles, D., Portmann, C.: –455G/A beta-fibrinogen gene polymorphism, factor V Leiden, prothrombin G20210A mutation and MTHFR C677T, and placental vascular complications. Blood Coagul Fibrinolysis, 2004, 15, 139–147.
Portmann C. , '–455G/A beta-fibrinogen gene polymorphism, factor V Leiden, prothrombin G20210A mutation and MTHFR C677T, and placental vascular complications ' (2004 ) 15 Blood Coagul Fibrinolysis : 139 -147.
Senden, I. P., de Groot, C. J., Steegers, E. A. és mtsai: Preeclampsia and the C282Y mutation in the hemochromatosis (HFE) gene. Clin. Chem., 2004, 50, 973–974.
Steegers E. A. , 'Preeclampsia and the C282Y mutation in the hemochromatosis (HFE) gene ' (2004 ) 50 Clin. Chem. : 973 -974.
Stonek, F., Hafner, E., Metzenbauer, M. és mtsai: Absence of an association of tumor necrosis factor (TNF)-alpha G308A, interleukin-6 (IL-6) G174C and interleukin-10 (IL-10) G1082A polymorphism in women with preeclampsia. J. Reprod. Immunol., 2008, 77, 85–90.
Metzenbauer M. , 'Absence of an association of tumor necrosis factor (TNF)-alpha G308A, interleukin-6 (IL-6) G174C and interleukin-10 (IL-10) G1082A polymorphism in women with preeclampsia ' (2008 ) 77 J. Reprod. Immunol. : 85 -90.
Chen, L. K., Huang, C. H., Yeh, H. M.: Polymorphisms in the endothelial nitric oxide synthase gene may be protective against preeclampsia in a Chinese population. Reprod. Sci., 2007, 14, 175–181.
Yeh H. M. , 'Polymorphisms in the endothelial nitric oxide synthase gene may be protective against preeclampsia in a Chinese population ' (2007 ) 14 Reprod. Sci. : 175 -181.
Fairchild, T. A., Fulton, D., Fontana, J. T. és mtsai: Acidic hydrolysis as a mechanism for the cleavage of the Glu(298) → Asp variant of human endothelial nitric-oxide synthase. J. Biol. Chem., 2001, 276, 26674–26679.
Fontana J. T. , 'Acidic hydrolysis as a mechanism for the cleavage of the Glu(298) → Asp variant of human endothelial nitric-oxide synthase ' (2001 ) 276 J. Biol. Chem. : 26674 -26679.
Doshi, A. A., Ziolo, M. T., Wang, H. és mtsai: A promoter polymorphism of the endothelial nitric oxide synthase gene is associated with reduced mRNA and protein expression in failing human myocardium. J. Card. Fail., 2010, 16, 314–319.
Wang H. , 'A promoter polymorphism of the endothelial nitric oxide synthase gene is associated with reduced mRNA and protein expression in failing human myocardium ' (2010 ) 16 J. Card. Fail. : 314 -319.
Bhatnagar, S., Bhattacharjee, J., Vaid, M. és mtsai: Inducible nitric oxide synthase (iNOS) gene polymorphism in pre-eclampsia: a pilot study in North India. Aust. N. Z. J. Obstet. Gynaecol., 2007, 47, 477–482.
Vaid M. , 'Inducible nitric oxide synthase (iNOS) gene polymorphism in pre-eclampsia: a pilot study in North India ' (2007 ) 47 Aust. N. Z. J. Obstet. Gynaecol. : 477 -482.
Lai, Y. L., Aoyama, S., Nagai, R. és mtsai: Inhibition of L-arginine metabolizing enzymes by L-arginine-derived advanced glycation end products. J. Clin. Biochem. Nutr., 2010, 46, 177–185.
Nagai R. , 'Inhibition of L-arginine metabolizing enzymes by L-arginine-derived advanced glycation end products ' (2010 ) 46 J. Clin. Biochem. Nutr. : 177 -185.
Huang, P. L.: eNOS, metabolic syndrome and cardiovascular disease. Trends Endocrinol. Metab., 2009, 20, 295–302.
Huang P. L. , 'eNOS, metabolic syndrome and cardiovascular disease ' (2009 ) 20 Trends Endocrinol. Metab. : 295 -302.
Xiao-Yun, X., Zhuo-Xiong, C., Min-Xiang, L. és mtsai: Ceramide mediates inhibition of the AKT/eNOS signaling pathway by palmitate in human vascular endothelial cells. Med. Sci. Monit., 2009, 15, BR254–BR261.
Min-Xiang L. , 'Ceramide mediates inhibition of the AKT/eNOS signaling pathway by palmitate in human vascular endothelial cells ' (2009 ) 15 Med. Sci. Monit. : BR254 -BR261.
Couloubaly, S., Deloménie, C., Rousseau, D. és mtsai: Fatty acid incorporation in endothelial cells and effects on endothelial nitric oxide synthase. Eur. J. Clin. Invest., 2007, 37, 692–699.
Rousseau D. , 'Fatty acid incorporation in endothelial cells and effects on endothelial nitric oxide synthase ' (2007 ) 37 Eur. J. Clin. Invest. : 692 -699.
Ness, R. B., Zhang, J., Bass, D. és mtsa: Interactions between smoking and weight in pregnancies complicated by preeclampsia and small-for-gestational-age birth. Am. J. Epidemiol., 2008, 15, 427–433.
Bass D. , 'Interactions between smoking and weight in pregnancies complicated by preeclampsia and small-for-gestational-age birth ' (2008 ) 15 Am. J. Epidemiol. : 427 -433.
Miller, E. C., Cao, H., Wen, S. W. és mtsai: The risk of adverse pregnancy outcomes is increased in preeclamptic women who smoke compared with nonpreeclamptic women who do not smoke. Am. J. Obstet. Gynecol., 2010, 203, 334.e1–334.e8.
Wen S. W. , 'The risk of adverse pregnancy outcomes is increased in preeclamptic women who smoke compared with nonpreeclamptic women who do not smoke ' (2010 ) 203 Am. J. Obstet. Gynecol. : 334.e1 -334.e8.
Wikström, A. K., Stephansson, O., Cnattingius, S.: Tobacco use during pregnancy and preeclampsia risk: effects of cigarette smoking and snuff. Hypertension, 2010, 55, 1254–1259.
Cnattingius S. , 'Tobacco use during pregnancy and preeclampsia risk: effects of cigarette smoking and snuff ' (2010 ) 55 Hypertension : 1254 -1259.
England, L. J., Levine, R. J., Mills, J. L. és mtsai: Adverse pregnancy outcomes in snuff users. Am. J. Obstet. Gynecol., 2003, 189, 939–943.
Mills J. L. , 'Adverse pregnancy outcomes in snuff users ' (2003 ) 189 Am. J. Obstet. Gynecol. : 939 -943.
Tóth, M., Kukor, Z., Valent, S.: Chemical stabilization of tetrahydrobiopterin by L-ascorbic acid: contribution to placental endothelial nitric oxide synthase activity. Mol. Hum. Reprod., 2002, 8, 271–280.
Valent S. , 'Chemical stabilization of tetrahydrobiopterin by L-ascorbic acid: contribution to placental endothelial nitric oxide synthase activity ' (2002 ) 8 Mol. Hum. Reprod. : 271 -280.
Valent, S., Tóth, M.: Activation energy determinations suggest that thiols reverse autooxidation of tetrahydrobiopterin by a different mechanism than ascorbate. Int. J. Biochem. Cell. Biol., 2006, 38, 1786–1793.
Tóth M. , 'Activation energy determinations suggest that thiols reverse autooxidation of tetrahydrobiopterin by a different mechanism than ascorbate ' (2006 ) 38 Int. J. Biochem. Cell. Biol. : 1786 -1793.
Lowe, E. R., Everett, A. C., Lee, A. J. és mtsai: Time-dependent inhibition and tetrahydrobiopterin depletion of endothelial nitric-oxide synthase caused by cigarettes. Drug Metab. Dispos., 2005, 33, 131–138.
Lee A. J. , 'Time-dependent inhibition and tetrahydrobiopterin depletion of endothelial nitric-oxide synthase caused by cigarettes ' (2005 ) 33 Drug Metab. Dispos. : 131 -138.
Wagner L., Laczy B., Cseh J. és mtsai: Cigarettafüst okozta elváltozások az endothelsejtekben. Hypertonia és Nephrologia, 2010, 14, 117–164.
Cseh J. , 'Cigarettafüst okozta elváltozások az endothelsejtekben ' (2010 ) 14 Hypertonia és Nephrologia : 117 -164.
Chung, H. T., Choi, B. M., Kwon, Y. G. és mtsa: Interactive relations between nitric oxide (NO) and carbon monoxide (CO): heme oxygenase-1/CO pathway is a key modulator in NO-mediated antiapoptosis and anti-inflammation. Methods Enzymol., 2008, 441, 329–338.
Kwon Y. G. , 'Interactive relations between nitric oxide (NO) and carbon monoxide (CO): heme oxygenase-1/CO pathway is a key modulator in NO-mediated antiapoptosis and anti-inflammation ' (2008 ) 441 Methods Enzymol. : 329 -338.
Underner, M., Peiffer, G.: Interpretation of exhaled CO levels in studies on smoking. Rev. Mal. Respir., 2010, 27, 293–300.
Peiffer G. , 'Interpretation of exhaled CO levels in studies on smoking ' (2010 ) 27 Rev. Mal. Respir. : 293 -300.
Ahmed, A., Cudmore, M. J.: Can the biology of VEGF and haem oxygenases help solve pre-eclampsia? Biochem. Soc. Trans., 2009, 37, 1237–1242.
Cudmore M. J. , 'Can the biology of VEGF and haem oxygenases help solve pre-eclampsia? ' (2009 ) 37 Biochem. Soc. Trans. : 1237 -1242.
Arias, H. R., Richards, N. D., Ghafoori, M. E. és mtsai: Role of non-neuronal nicotinic acetylcholine receptors in angiogenesis. Int. J. Biochem. Cell Biol., 2009, 41, 1441–1451.
Ghafoori M. E. , 'Role of non-neuronal nicotinic acetylcholine receptors in angiogenesis ' (2009 ) 41 Int. J. Biochem. Cell Biol. : 1441 -1451.
Hwang, J. T., Kwon, D. Y,, Yoon, S. H.: AMP-activated protein kinase: a potential target for the diseases prevention by natural occurring polyphenols. N. Biotechnol., 2009, 26, 17–22.
Yoon S. H. , 'AMP-activated protein kinase: a potential target for the diseases prevention by natural occurring polyphenols ' (2009 ) 26 N. Biotechnol. : 17 -22.
Wang, S., Zhang, M., Liang, B. és mtsai: AMPKalpha2 deletion causes aberrant expression and activation of NAD(P)H oxidase and consequent endothelial dysfunction in vivo: role of 26S proteasomes. Circ. Res., 2010, 106, 1117–1128.
Liang B. , 'AMPKalpha2 deletion causes aberrant expression and activation of NAD(P)H oxidase and consequent endothelial dysfunction in vivo: role of 26S proteasomes ' (2010 ) 106 Circ. Res. : 1117 -1128.
Wang, S., Xu, J., Song, P. és mtsai: In vivo activation of AMP-activated protein kinase attenuates diabetes-enhanced degradation of GTP cyclohydrolase I. Diabetes, 2009, 58, 1893–901.
Song P. , 'In vivo activation of AMP-activated protein kinase attenuates diabetes-enhanced degradation of GTP cyclohydrolase I ' (2009 ) 58 Diabetes : 1893 -901.
Rios, D. L. S., D’Onofrio, L. O., Souza, J. K. és mtsai: Smoking-dependent and haplotype-specific effects of endothelial nitric oxide synthase gene polymorphisms on angiographically assessed coronary artery disease in Caucasian- and African-Brazilians. J. Hum. Hypertens., 2005, 19, 233–240.
Souza J. K. , 'Smoking-dependent and haplotype-specific effects of endothelial nitric oxide synthase gene polymorphisms on angiographically assessed coronary artery disease in Caucasian- and African-Brazilians ' (2005 ) 19 J. Hum. Hypertens. : 233 -240.
Villa, P. M., Laivuori, H., Kajantie, E. és mtsa: Free fatty acid profiles in preeclampsia. Prostaglandins Leukot. Essent. Fatty Acids, 2009, 81, 17–21.
Kajantie E. , 'Free fatty acid profiles in preeclampsia ' (2009 ) 81 Prostaglandins Leukot. Essent. Fatty Acids : 17 -21.
Mehendale, S., Kilari, A., Dangat, K. és mtsai: Fatty acids, antioxidants, and oxidative stress in pre-eclampsia. Int. J. Gynaecol. Obstet., 2008, 100, 234–238.
Dangat K. , 'Fatty acids, antioxidants, and oxidative stress in pre-eclampsia ' (2008 ) 100 Int. J. Gynaecol. Obstet. : 234 -238.
Gandley, R. E., Tyurin, V. A., Huang, W. és mtsai: S-nitrosoalbumin-mediated relaxation is enhanced by ascorbate and copper: effects in pregnancy and preeclampsia plasma. Hypertension, 2005, 45, 21–27.
Huang W. , 'S-nitrosoalbumin-mediated relaxation is enhanced by ascorbate and copper: effects in pregnancy and preeclampsia plasma ' (2005 ) 45 Hypertension : 21 -27.
Rytlewski, K., Olszanecki, R., Korbut, R. és mtsa: Effects of prolonged oral supplementation with l-arginine on blood pressure and nitric oxide synthesis in preeclampsia. Eur. J. Clin. Invest., 2005, 35, 32–37.
Korbut R. , 'Effects of prolonged oral supplementation with l-arginine on blood pressure and nitric oxide synthesis in preeclampsia ' (2005 ) 35 Eur. J. Clin. Invest. : 32 -37.
Ray, J. G., Laskin, C. A.: Folic acid and homocyst(e)ine metabolic defects and the risk of placental abruption, pre-eclampsia and spontaneous pregnancy loss: A systematic review. Placenta, 1999, 20, 519–529.
Laskin C. A. , 'Folic acid and homocyst(e)ine metabolic defects and the risk of placental abruption, pre-eclampsia and spontaneous pregnancy loss: A systematic review ' (1999 ) 20 Placenta : 519 -529.
Cetin, A., Yurtcu, N., Guvenal, T. és mtsai: The effect of glyceryl trinitrate on hypertension in women with severe preeclampsia, HELLP syndrome, and eclampsia. Hypertens. Pregnancy, 2004, 23, 37–46.
Guvenal T. , 'The effect of glyceryl trinitrate on hypertension in women with severe preeclampsia, HELLP syndrome, and eclampsia ' (2004 ) 23 Hypertens. Pregnancy : 37 -46.